Profil
John M.
McCall is the founder and current Chairman & Vice President-Chemistry of ReveraGen BioPharma, Inc. which is founded in 2008.
Postes actifs de John McCall
| Sociétés | Poste | Début |
|---|---|---|
ReveraGen BioPharma, Inc.
 ReveraGen BioPharma, Inc. Pharmaceuticals: MajorHealth Technology ReveraGen BioPharma, Inc. operates as a small clinical-stage drug development company. It develops therapeutics for Duchenne muscular dystrophy. The company was founded by Eric P. Hoffman, John M. McCall and Kanneboyina Nagaraju in 2008 and is headquartered in Rockville, MD. | Fondateur | 01/01/2008 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ReveraGen BioPharma, Inc.
ReveraGen BioPharma, Inc. Pharmaceuticals: MajorHealth Technology ReveraGen BioPharma, Inc. operates as a small clinical-stage drug development company. It develops therapeutics for Duchenne muscular dystrophy. The company was founded by Eric P. Hoffman, John M. McCall and Kanneboyina Nagaraju in 2008 and is headquartered in Rockville, MD. | Health Technology |
